As TGF-β has many important effects on cancers, particularly in relation to differentiation status and stimulating epithelial to mesenchymal transition (EMT) this interaction may have potential implications for interactions between the insulin/IGF-system and these other regulatory pathways. Here, IGF1 is linked to cancer.